As of 20 Sept 2026, Aptus Pharma Ltd share price is ₹353.40. The stock opened at ₹353.40 and had closed at ₹346.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹32.32 and a high of ₹360.60. In terms of performance, Aptus Pharma Ltd share price has increased by 153.04% over the past six months and has increased by 941.25% over the last year.
Aptus Pharma Stock Price Chart
Aptus Pharma Ltd Overview
About Aptus Pharma
Aptus Pharma is engaged in the business of manufacturing, marketing, and cutrihution of finished pharmacnutcal formulations.
Aptus Pharma Ltd Historical Performance
Aptus Pharma Ltd Fundamentals
Aptus Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Revenue | 46.70 | 24.64 | 17.89 | 13.90 |
| EBITDA | 7.58 | 4.93 | 1.57 | 0.62 |
| Net Profit | 4.62 | 2.96 | 0.80 | 0.19 |
| EPS | 7.78 | 6.08 | 26.60 | 6.48 |
Aptus Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 341.80 |
| Resistance 1 (R1) | 355.90 |
| Pivot Point | 351.20 |
Aptus Pharma Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Tejash Maheshchandra Hathi | Managing Director |
| CHETAN SHANTILAL LALSETA | Non Executive Director |
| Jyotiben Hasmukhbhai Chandarana | Non Executive Director |
Aptus Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,837.30-1.61% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,375.00+0.56% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,840.00-0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aptus Pharma Ltd today is ₹353.40 on NSE and ₹353.40 on BSE.
- The 52-week high of Aptus Pharma Ltd is ₹360.60, while the 52-week low is ₹32.32.
- The current market capitalisation of Aptus Pharma Ltd is approximately ₹606 crore.
- The P/E (Price-to-Earnings) ratio of Aptus Pharma Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aptus Pharma Ltd is 25.96. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aptus Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Aptus Pharma on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aptus Pharma Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aptus Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 72.89% promoters, 0.00% FIIs, 0.00% DIIs, and 24.03% public shareholders.

